Tapewire

Nasdaq · USD

MAZE

Maze Therapeutics, Inc.

Export transactions ↓
Tapewire entity
1775
SEC CIK
0001842295
Parsed reports
106

Last 12 months

Inside the activity.

0 purchase rows · 95 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202508
Jan 2026011
Feb 202609
Mar 202609
Apr 202606
May 202607
Jun 202608
Jul 202607
Aug 202606
Sep 2026021
Oct 202603

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
October 01, 2026 Filed Oct 3, 2026 00:12 UTC
Coloma Jason VDirector · Chief Executive Officer
SaleCommon Stock 31,908 $27.02 $862,186.07
Disclosure

SEC source: 0001676170-26-000024 · form4-10022026_081010.xml · nonDerivative · entry 2

Coloma Jason V · CIK 0001676170 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · Coloma Family Trust

Disclosed balance after: 191,447

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026.

F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.585 to $27.47 per share, inclusive.

F5 · ownership.nature: These securities are directly held by the Coloma Family Trust, for which the reporting person and his spouse serve as co-trustees.

Read SEC document
October 01, 2026 Filed Oct 3, 2026 00:12 UTC
Coloma Jason VDirector · Chief Executive Officer
SaleCommon Stock 2,593 $27.02 $70,073.49
Disclosure

SEC source: 0001676170-26-000024 · form4-10022026_081010.xml · nonDerivative · entry 1

Coloma Jason V · CIK 0001676170 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · The Coloma 2021 Irrevocable Trust

Disclosed balance after: 15,558

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026.

F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.645 to $27.46 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnote 4 of this Form 4.

F3 · ownership.nature: These securities are directly held by The Coloma 2021 Irrevocable Trust, for which the reporting person and his spouse serve as co-trustees.

Read SEC document
October 01, 2026 Filed Oct 3, 2026 00:09 UTC
Bernstein HaroldPresident, R&D & CMO
Exercise / conversionStock Option (Right to Buy) · Derivative 16,141 $0.00 Strike: $10.42 $0.00
Disclosure

SEC source: 0002050172-26-000038 · form4-10022026_081053.xml · derivative · entry 3

Bernstein Harold · CIK 0002050172 · President, R&D & CMO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 144,521

Underlying: Common Stock · 16,141 shares

Expires 2032-10-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.

F3 · derivative.exercise_date: The option vested as to 1/4th of the total award on October 3, 2023, and thereafter vested or vests as to 1/48th of the total award on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date.

Read SEC document
October 01, 2026 Filed Oct 3, 2026 00:09 UTC
Bernstein HaroldPresident, R&D & CMO
SaleCommon Stock 16,141 $26.93 $434,743.31
Disclosure

SEC source: 0002050172-26-000038 · form4-10022026_081053.xml · nonDerivative · entry 2

Bernstein Harold · CIK 0002050172 · President, R&D & CMO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.

F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.56 to $27.47 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
October 01, 2026 Filed Oct 3, 2026 00:09 UTC
Bernstein HaroldPresident, R&D & CMO
Exercise / conversionCommon Stock 16,141 $10.42 $168,189.22
Disclosure

SEC source: 0002050172-26-000038 · form4-10022026_081053.xml · nonDerivative · entry 1

Bernstein Harold · CIK 0002050172 · President, R&D & CMO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 16,141

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.

Read SEC document
September 29, 2026 Filed Oct 2, 2026 00:06 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 7,500 $0.00 Strike: $10.42 $0.00
Disclosure

SEC source: 0002050167-26-000030 · form4-10012026_081054.xml · derivative · entry 3

Dandekar Atul · CIK 0002050167 · CSBO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 6,643

Underlying: Common Stock · 7,500 shares

Expires 2031-04-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.

F3 · derivative.exercise_date: The option is fully vested. Pursuant to the terms of the reporting person's award agreement with the Issuer, the award became fully vested on March 17, 2025.

Read SEC document
September 29, 2026 Filed Oct 2, 2026 00:06 UTC SaleCommon Stock 7,500 $27.06 $202,920.75
Disclosure

SEC source: 0002050167-26-000030 · form4-10012026_081054.xml · nonDerivative · entry 2

Dandekar Atul · CIK 0002050167 · CSBO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 32,316

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.

F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.47 to $27.45 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
September 29, 2026 Filed Oct 2, 2026 00:06 UTC Exercise / conversionCommon Stock 7,500 $10.42 $78,150.00
Disclosure

SEC source: 0002050167-26-000030 · form4-10012026_081054.xml · nonDerivative · entry 1

Dandekar Atul · CIK 0002050167 · CSBO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 39,816

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.

Read SEC document
September 04, 2026 Filed Sep 8, 2026 20:20 UTC
Bernstein HaroldPresident, R&D & CMO
SaleCommon Stock 9,705 $26.22 $254,501.98
Disclosure

SEC source: 0002050172-26-000036 · form4-09082026_080930.xml · nonDerivative · entry 1

Bernstein Harold · CIK 0002050172 · President, R&D & CMO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.

F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.77 to $26.42 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
September 03, 2026 Filed Sep 4, 2026 20:27 UTC
Courtney PhillipsGC and Corp. Secretary
SaleCommon Stock 22 $25.78 $567.16
Disclosure

SEC source: 0001782758-26-000008 · form4-09042026_080910.xml · nonDerivative · entry 4

Courtney Phillips · CIK 0001782758 · GC and Corp. Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,007

F1 · kind: The reported transaction represents shares of the Issuer's Common Stock sold to satisfy tax withholding obligations incurred in connection with the vesting of restricted stock units.

Read SEC document
September 03, 2026 Filed Sep 4, 2026 20:27 UTC
Courtney PhillipsGC and Corp. Secretary
SaleCommon Stock 1,990 $26.01 $51,766.47
Disclosure

SEC source: 0001782758-26-000008 · form4-09042026_080910.xml · nonDerivative · entry 3

Courtney Phillips · CIK 0001782758 · GC and Corp. Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,029

F1 · kind: The reported transaction represents shares of the Issuer's Common Stock sold to satisfy tax withholding obligations incurred in connection with the vesting of restricted stock units.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.743 to $26.65 per share, inclusive.

Read SEC document
September 03, 2026 Filed Sep 4, 2026 20:25 UTC SaleCommon Stock 36 $25.81 $929.16
Disclosure

SEC source: 0002050167-26-000027 · form4-09042026_080945.xml · nonDerivative · entry 4

Dandekar Atul · CIK 0002050167 · CSBO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,316

F1 · kind: The reported transaction represents shares of the Issuer's Common Stock sold to satisfy tax withholding obligations incurred in connection with the vesting of restricted stock units.

Read SEC document
September 03, 2026 Filed Sep 4, 2026 20:25 UTC SaleCommon Stock 3,207 $26.01 $83,424.65
Disclosure

SEC source: 0002050167-26-000027 · form4-09042026_080945.xml · nonDerivative · entry 3

Dandekar Atul · CIK 0002050167 · CSBO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,352

F1 · kind: The reported transaction represents shares of the Issuer's Common Stock sold to satisfy tax withholding obligations incurred in connection with the vesting of restricted stock units.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.743 to $26.65 per share, inclusive.

Read SEC document
September 03, 2026 Filed Sep 4, 2026 20:24 UTC
Coloma Jason VDirector · Chief Executive Officer
SaleCommon Stock 129 $25.77 $3,324.96
Disclosure

SEC source: 0001676170-26-000022 · form4-09042026_080923.xml · nonDerivative · entry 4

Coloma Jason V · CIK 0001676170 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,362

F1 · kind: The reported transaction represents shares of the Issuer's Common Stock sold to satisfy tax withholding obligations incurred in connection with the vesting of restricted stock units.

Read SEC document
September 03, 2026 Filed Sep 4, 2026 20:24 UTC
Coloma Jason VDirector · Chief Executive Officer
SaleCommon Stock 11,282 $26.01 $293,482.05
Disclosure

SEC source: 0001676170-26-000022 · form4-09042026_080923.xml · nonDerivative · entry 3

Coloma Jason V · CIK 0001676170 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,491

F1 · kind: The reported transaction represents shares of the Issuer's Common Stock sold to satisfy tax withholding obligations incurred in connection with the vesting of restricted stock units.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.743 to $26.65 per share, inclusive.

Read SEC document
September 03, 2026 Filed Sep 4, 2026 20:22 UTC
Bernstein HaroldPresident, R&D & CMO
SaleCommon Stock 59 $25.78 $1,521.02
Disclosure

SEC source: 0002050172-26-000034 · form4-09042026_080958.xml · nonDerivative · entry 4

Bernstein Harold · CIK 0002050172 · President, R&D & CMO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,705

F1 · kind: The reported transaction represents shares of the Issuer's Common Stock sold to satisfy tax withholding obligations incurred in connection with the vesting of restricted stock units.

Read SEC document
September 03, 2026 Filed Sep 4, 2026 20:22 UTC
Bernstein HaroldPresident, R&D & CMO
SaleCommon Stock 5,130 $26.01 $133,448.23
Disclosure

SEC source: 0002050172-26-000034 · form4-09042026_080958.xml · nonDerivative · entry 3

Bernstein Harold · CIK 0002050172 · President, R&D & CMO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,764

F1 · kind: The reported transaction represents shares of the Issuer's Common Stock sold to satisfy tax withholding obligations incurred in connection with the vesting of restricted stock units.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.743 to $26.65 per share, inclusive.

Read SEC document
September 02, 2026 Filed Sep 4, 2026 20:27 UTC
Courtney PhillipsGC and Corp. Secretary
SaleCommon Stock 243 $27.12 $6,590.43
Disclosure

SEC source: 0001782758-26-000008 · form4-09042026_080910.xml · nonDerivative · entry 2

Courtney Phillips · CIK 0001782758 · GC and Corp. Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,019

F1 · kind: The reported transaction represents shares of the Issuer's Common Stock sold to satisfy tax withholding obligations incurred in connection with the vesting of restricted stock units.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.055 to $27.40 per share, inclusive.

Read SEC document
September 02, 2026 Filed Sep 4, 2026 20:27 UTC
Courtney PhillipsGC and Corp. Secretary
SaleCommon Stock 1,738 $26.38 $45,841.49
Disclosure

SEC source: 0001782758-26-000008 · form4-09042026_080910.xml · nonDerivative · entry 1

Courtney Phillips · CIK 0001782758 · GC and Corp. Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,262

F1 · kind: The reported transaction represents shares of the Issuer's Common Stock sold to satisfy tax withholding obligations incurred in connection with the vesting of restricted stock units.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.03 to $27.00 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnotes 3 and 4 of this Form 4.

Read SEC document
September 02, 2026 Filed Sep 4, 2026 20:25 UTC SaleCommon Stock 391 $27.12 $10,604.35
Disclosure

SEC source: 0002050167-26-000027 · form4-09042026_080945.xml · nonDerivative · entry 2

Dandekar Atul · CIK 0002050167 · CSBO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,559

F1 · kind: The reported transaction represents shares of the Issuer's Common Stock sold to satisfy tax withholding obligations incurred in connection with the vesting of restricted stock units.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.055 to $27.40 per share, inclusive.

Read SEC document
September 02, 2026 Filed Sep 4, 2026 20:25 UTC SaleCommon Stock 2,800 $26.38 $73,852.80
Disclosure

SEC source: 0002050167-26-000027 · form4-09042026_080945.xml · nonDerivative · entry 1

Dandekar Atul · CIK 0002050167 · CSBO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,950

F1 · kind: The reported transaction represents shares of the Issuer's Common Stock sold to satisfy tax withholding obligations incurred in connection with the vesting of restricted stock units.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.03 to $27.00 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnotes 3 and 4 of this Form 4.

Read SEC document
September 02, 2026 Filed Sep 4, 2026 20:24 UTC
Coloma Jason VDirector · Chief Executive Officer
SaleCommon Stock 1,375 $27.12 $37,291.51
Disclosure

SEC source: 0001676170-26-000022 · form4-09042026_080923.xml · nonDerivative · entry 2

Coloma Jason V · CIK 0001676170 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,773

F1 · kind: The reported transaction represents shares of the Issuer's Common Stock sold to satisfy tax withholding obligations incurred in connection with the vesting of restricted stock units.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.055 to $27.40 per share, inclusive.

Read SEC document
September 02, 2026 Filed Sep 4, 2026 20:24 UTC
Coloma Jason VDirector · Chief Executive Officer
SaleCommon Stock 9,852 $26.38 $259,856.35
Disclosure

SEC source: 0001676170-26-000022 · form4-09042026_080923.xml · nonDerivative · entry 1

Coloma Jason V · CIK 0001676170 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,148

F1 · kind: The reported transaction represents shares of the Issuer's Common Stock sold to satisfy tax withholding obligations incurred in connection with the vesting of restricted stock units.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.03 to $27.00 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnotes 3 and 4 of this Form 4.

Read SEC document
September 02, 2026 Filed Sep 4, 2026 20:22 UTC
Bernstein HaroldPresident, R&D & CMO
SaleCommon Stock 625 $27.12 $16,950.69
Disclosure

SEC source: 0002050172-26-000034 · form4-09042026_080958.xml · nonDerivative · entry 2

Bernstein Harold · CIK 0002050172 · President, R&D & CMO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,894

F1 · kind: The reported transaction represents shares of the Issuer's Common Stock sold to satisfy tax withholding obligations incurred in connection with the vesting of restricted stock units.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.055 to $27.40 per share, inclusive.

Read SEC document
September 02, 2026 Filed Sep 4, 2026 20:22 UTC
Bernstein HaroldPresident, R&D & CMO
SaleCommon Stock 4,481 $26.38 $118,190.86
Disclosure

SEC source: 0002050172-26-000034 · form4-09042026_080958.xml · nonDerivative · entry 1

Bernstein Harold · CIK 0002050172 · President, R&D & CMO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,519

F1 · kind: The reported transaction represents shares of the Issuer's Common Stock sold to satisfy tax withholding obligations incurred in connection with the vesting of restricted stock units.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.03 to $27.00 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnotes 3 and 4 of this Form 4.

Read SEC document
September 01, 2026 Filed Sep 3, 2026 20:31 UTC
Courtney PhillipsGC and Corp. Secretary
Exercise / conversionRestricted Stock Units · Derivative 11,000 $0.00 $0.00
Disclosure

SEC source: 0001782758-26-000006 · form4-09032026_080954.xml · derivative · entry 2

Courtney Phillips · CIK 0001782758 · GC and Corp. Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,000

Underlying: Common Stock · 11,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock upon settlement.

F2 · derivative.exercise_date: The award vested or vests as to 1/2 of the total award on September 1, 2026 and September 1, 2027, subject to the reporting person's continued service to the Issuer on each vesting date.

F3 · derivative.expiration_date: These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date.

Read SEC document
September 01, 2026 Filed Sep 3, 2026 20:31 UTC
Courtney PhillipsGC and Corp. Secretary
Exercise / conversionCommon Stock 11,000 $0.00 $0.00
Disclosure

SEC source: 0001782758-26-000006 · form4-09032026_080954.xml · nonDerivative · entry 1

Courtney Phillips · CIK 0001782758 · GC and Corp. Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 01, 2026 Filed Sep 3, 2026 20:29 UTC Exercise / conversionRestricted Stock Units · Derivative 12,500 $0.00 $0.00
Disclosure

SEC source: 0002050167-26-000025 · form4-09032026_080935.xml · derivative · entry 2

Dandekar Atul · CIK 0002050167 · CSBO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,500

Underlying: Common Stock · 12,500 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock upon settlement.

F2 · derivative.exercise_date: The award vested or vests as to 1/2 of the total award on September 1, 2026 and September 1, 2027, subject to the reporting person's continued service to the Issuer on each vesting date.

F3 · derivative.expiration_date: These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date.

Read SEC document
September 01, 2026 Filed Sep 3, 2026 20:29 UTC Exercise / conversionCommon Stock 12,500 $0.00 $0.00
Disclosure

SEC source: 0002050167-26-000025 · form4-09032026_080935.xml · nonDerivative · entry 1

Dandekar Atul · CIK 0002050167 · CSBO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,750

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 01, 2026 Filed Sep 3, 2026 20:27 UTC
Coloma Jason VDirector · Chief Executive Officer
Exercise / conversionRestricted Stock Units · Derivative 50,000 $0.00 $0.00
Disclosure

SEC source: 0001676170-26-000020 · form4-09032026_080937.xml · derivative · entry 4

Coloma Jason V · CIK 0001676170 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock upon settlement.

F7 · derivative.exercise_date: The award vested or vests as to 1/2 of the total award on September 1, 2026 and September 1, 2027, subject to the reporting person's continued service to the Issuer on each vesting date.

F8 · derivative.expiration_date: These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date.

Read SEC document
September 01, 2026 Filed Sep 3, 2026 20:27 UTC
Coloma Jason VDirector · Chief Executive Officer
Exercise / conversionCommon Stock 50,000 $0.00 $0.00
Disclosure

SEC source: 0001676170-26-000020 · form4-09032026_080937.xml · nonDerivative · entry 3

Coloma Jason V · CIK 0001676170 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 50,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 01, 2026 Filed Sep 3, 2026 20:27 UTC
Coloma Jason VDirector · Chief Executive Officer
SaleCommon Stock 31,908 $26.29 $838,784.74
Disclosure

SEC source: 0001676170-26-000020 · form4-09032026_080937.xml · nonDerivative · entry 2

Coloma Jason V · CIK 0001676170 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · Coloma Family Trust

Disclosed balance after: 223,355

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026.

F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.13 to $26.555 per share, inclusive.

F5 · ownership.nature: These securities are directly held by the Coloma Family Trust, for which the reporting person and his spouse serve as co-trustees.

Read SEC document
September 01, 2026 Filed Sep 3, 2026 20:27 UTC
Coloma Jason VDirector · Chief Executive Officer
SaleCommon Stock 2,593 $26.31 $68,214.05
Disclosure

SEC source: 0001676170-26-000020 · form4-09032026_080937.xml · nonDerivative · entry 1

Coloma Jason V · CIK 0001676170 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · The Coloma 2021 Irrevocable Trust

Disclosed balance after: 18,151

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026.

F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.14 to $26.50 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnote 4 of this Form 4.

F3 · ownership.nature: These securities are directly held by The Coloma 2021 Irrevocable Trust, for which the reporting person and his spouse serve as co-trustees.

Read SEC document
September 01, 2026 Filed Sep 3, 2026 20:24 UTC
Bernstein HaroldPresident, R&D & CMO
Exercise / conversionRestricted Stock Units · Derivative 20,000 $0.00 $0.00
Disclosure

SEC source: 0002050172-26-000032 · form4-09032026_080957.xml · derivative · entry 5

Bernstein Harold · CIK 0002050172 · President, R&D & CMO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock upon settlement.

F5 · derivative.exercise_date: The award vested or vests as to 1/2 of the total award on September 1, 2026 and September 1, 2027, subject to the reporting person's continued service to the Issuer on each vesting date.

F6 · derivative.expiration_date: These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date.

Read SEC document
September 01, 2026 Filed Sep 3, 2026 20:24 UTC
Bernstein HaroldPresident, R&D & CMO
Exercise / conversionStock Option (Right to Buy) · Derivative 16,141 $0.00 Strike: $10.42 $0.00
Disclosure

SEC source: 0002050172-26-000032 · form4-09032026_080957.xml · derivative · entry 4

Bernstein Harold · CIK 0002050172 · President, R&D & CMO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 160,662

Underlying: Common Stock · 16,141 shares

Expires 2032-10-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.

F3 · derivative.exercise_date: The option vested as to 1/4th of the total award on October 3, 2023, and thereafter vested or vests as to 1/48th of the total award on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date.

Read SEC document
September 01, 2026 Filed Sep 3, 2026 20:24 UTC
Bernstein HaroldPresident, R&D & CMO
Exercise / conversionCommon Stock 20,000 $0.00 $0.00
Disclosure

SEC source: 0002050172-26-000032 · form4-09032026_080957.xml · nonDerivative · entry 3

Bernstein Harold · CIK 0002050172 · President, R&D & CMO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 20,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 01, 2026 Filed Sep 3, 2026 20:24 UTC
Bernstein HaroldPresident, R&D & CMO
SaleCommon Stock 16,141 $26.36 $425,512.27
Disclosure

SEC source: 0002050172-26-000032 · form4-09032026_080957.xml · nonDerivative · entry 2

Bernstein Harold · CIK 0002050172 · President, R&D & CMO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.

F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.11 to $26.64 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
September 01, 2026 Filed Sep 3, 2026 20:24 UTC
Bernstein HaroldPresident, R&D & CMO
Exercise / conversionCommon Stock 16,141 $10.42 $168,189.22
Disclosure

SEC source: 0002050172-26-000032 · form4-09032026_080957.xml · nonDerivative · entry 1

Bernstein Harold · CIK 0002050172 · President, R&D & CMO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 16,141

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.

Read SEC document
August 28, 2026 Filed Aug 31, 2026 22:32 UTC Exercise / conversionStock Option (Right to Buy) · Derivative 7,500 $0.00 Strike: $10.42 $0.00
Disclosure

SEC source: 0002050167-26-000023 · form4-08312026_100823.xml · derivative · entry 3

Dandekar Atul · CIK 0002050167 · CSBO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 14,143

Underlying: Common Stock · 7,500 shares

Expires 2031-04-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.

F3 · derivative.exercise_date: The option is fully vested. Pursuant to the terms of the reporting person's award agreement with the Issuer, the award became fully vested on March 17, 2025.

Read SEC document
August 28, 2026 Filed Aug 31, 2026 22:32 UTC SaleCommon Stock 7,500 $27.58 $206,823.75
Disclosure

SEC source: 0002050167-26-000023 · form4-08312026_100823.xml · nonDerivative · entry 2

Dandekar Atul · CIK 0002050167 · CSBO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 26,250

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.

F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.31 to $28.01 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
August 28, 2026 Filed Aug 31, 2026 22:32 UTC Exercise / conversionCommon Stock 7,500 $10.42 $78,150.00
Disclosure

SEC source: 0002050167-26-000023 · form4-08312026_100823.xml · nonDerivative · entry 1

Dandekar Atul · CIK 0002050167 · CSBO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 33,750

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.

Read SEC document
August 13, 2026 Filed Aug 14, 2026 20:54 UTC
Bernstein HaroldPresident, R&D & CMO
Exercise / conversionStock Option (Right to Buy) · Derivative 16,142 $0.00 Strike: $10.42 $0.00
Disclosure

SEC source: 0002050172-26-000028 · form4-08142026_080845.xml · derivative · entry 3

Bernstein Harold · CIK 0002050172 · President, R&D & CMO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 176,803

Underlying: Common Stock · 16,142 shares

Expires 2032-10-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.

F3 · derivative.exercise_date: The option vested as to 1/4th of the total award on October 3, 2023, and thereafter vested or vests as to 1/48th of the total award on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date.

Read SEC document
August 13, 2026 Filed Aug 14, 2026 20:54 UTC
Bernstein HaroldPresident, R&D & CMO
SaleCommon Stock 16,142 $27.61 $445,620.89
Disclosure

SEC source: 0002050172-26-000028 · form4-08142026_080845.xml · nonDerivative · entry 2

Bernstein Harold · CIK 0002050172 · President, R&D & CMO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.

F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.17 to $28.00 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
August 13, 2026 Filed Aug 14, 2026 20:54 UTC
Bernstein HaroldPresident, R&D & CMO
Exercise / conversionCommon Stock 16,142 $10.42 $168,199.64
Disclosure

SEC source: 0002050172-26-000028 · form4-08142026_080845.xml · nonDerivative · entry 1

Bernstein Harold · CIK 0002050172 · President, R&D & CMO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 16,142

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.

Read SEC document
August 13, 2026 Filed Aug 17, 2026 20:51 UTC GrantStock Option (Right to Buy) · Derivative 36,000 $0.00 Strike: $27.67 $0.00
Disclosure

SEC source: 0001341161-26-000005 · form4-08172026_080804.xml · derivative · entry 1

Johnson Paula A · CIK 0001341161 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,000

Underlying: Common Stock · 36,000 shares

Expires 2036-08-12

F1 · derivative.exercise_date: The option shall vest as to 1/36th of the total award monthly, with the first tranche vesting on September 13, 2026, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date.

Read SEC document
August 13, 2026 Filed Aug 17, 2026 20:52 UTC GrantStock Option (Right to Buy) · Derivative 36,000 $0.00 Strike: $27.67 $0.00
Disclosure

SEC source: 0001894117-26-000006 · form4-08172026_080820.xml · derivative · entry 1

Kornowski Sophie · CIK 0001894117 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,000

Underlying: Common Stock · 36,000 shares

Expires 2036-08-12

F1 · derivative.exercise_date: The option shall vest as to 1/36th of the total award monthly, with the first tranche vesting on September 13, 2026, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date.

Read SEC document
August 03, 2026 Filed Aug 5, 2026 20:08 UTC
Coloma Jason VDirector · Chief Executive Officer
SaleCommon Stock 1,604 $27.09 $43,444.82
Disclosure

SEC source: 0001676170-26-000016 · form4-08052026_080854.xml · nonDerivative · entry 4

Coloma Jason V · CIK 0001676170 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · Coloma Family Trust

Disclosed balance after: 255,263

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026.

F7 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.04 to $27.19 per share, inclusive.

F6 · ownership.nature: These securities are directly held by the Coloma Family Trust, for which the reporting person and his spouse serve as co-trustees.

Read SEC document
August 03, 2026 Filed Aug 5, 2026 20:08 UTC
Coloma Jason VDirector · Chief Executive Officer
SaleCommon Stock 30,304 $26.71 $809,541.06
Disclosure

SEC source: 0001676170-26-000016 · form4-08052026_080854.xml · nonDerivative · entry 3

Coloma Jason V · CIK 0001676170 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · Coloma Family Trust

Disclosed balance after: 256,867

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026.

F5 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.005 to $26.985 per share, inclusive.

F6 · ownership.nature: These securities are directly held by the Coloma Family Trust, for which the reporting person and his spouse serve as co-trustees.

Read SEC document
August 03, 2026 Filed Aug 5, 2026 20:08 UTC
Coloma Jason VDirector · Chief Executive Officer
SaleCommon Stock 154 $27.09 $4,172.48
Disclosure

SEC source: 0001676170-26-000016 · form4-08052026_080854.xml · nonDerivative · entry 2

Coloma Jason V · CIK 0001676170 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · The Coloma 2021 Irrevocable Trust

Disclosed balance after: 20,744

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026.

F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.04 to $27.16 per share, inclusive.

F3 · ownership.nature: These securities are directly held by The Coloma 2021 Irrevocable Trust, for which the reporting person and his spouse serve as co-trustees.

Read SEC document
August 03, 2026 Filed Aug 5, 2026 20:08 UTC
Coloma Jason VDirector · Chief Executive Officer
SaleCommon Stock 2,439 $26.71 $65,156.67
Disclosure

SEC source: 0001676170-26-000016 · form4-08052026_080854.xml · nonDerivative · entry 1

Coloma Jason V · CIK 0001676170 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Indirect · The Coloma 2021 Irrevocable Trust

Disclosed balance after: 20,898

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 6, 2026.

F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.01 to $26.97 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnotes 4, 5, and 7 of this Form 4.

F3 · ownership.nature: These securities are directly held by The Coloma 2021 Irrevocable Trust, for which the reporting person and his spouse serve as co-trustees.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.